Repositorio Dspace

Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert's Document Based on a Systematic Literature Review and Extended Delphi Process

Mostrar el registro sencillo del ítem

dc.contributor.author García-Vicuna, Rosario
dc.contributor.author Juanola, Xavier
dc.contributor.author Navarro-Compan, Victoria
dc.contributor.author Moreno-Ramos, Manuel-José
dc.contributor.author Castillo-Gallego, Concepción
dc.contributor.author Moreno, Mireia
dc.contributor.author Galindez, Eva
dc.contributor.author Montoro, María
dc.contributor.author Gómez, Ismael
dc.contributor.author Rebollo-Laserna, Francisco-José
dc.contributor.author Loza, Estibaliz
dc.date.accessioned 2025-11-19T12:39:52Z
dc.date.available 2025-11-19T12:39:52Z
dc.date.issued 2023-10
dc.identifier.issn 2198-6576
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21180
dc.description.abstract INTRODUCTION: The management of specific clinical scenarios is not adequately addressed in national and international guidelines for axial spondyloarthritis (axSpA). Expert opinions could serve as a valuable complement to these documents. METHODS: Seven expert rheumatologists identified controversial areas or gaps of current recommendations for the management of patients with axSpA. A systematic literature review (SLR) was performed to analyze the efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs (csDMARDs, b/tsDMARDs) in axSpA regarding controversial areas or gaps. In a nominal group meeting, the results of the SLR were discussed and a set of statements were proposed. A Delphi process inviting 150 rheumatologists was followed to define the final statements. Agreement was defined as if at least 70% of the participants voted ? 7 (from 1, totally disagree, to 10, totally agree). RESULTS: Three overarching principles and 17 recommendations were generated. All reached agreement. According to them, axSpA care should be holistic and individualized, taking into account objective findings, comorbidities, and patients' opinions and preferences. Integrating imaging and clinical assessment with biomarker analysis could also help in decision-making. Connected to treatments, in refractory enthesitis, b/tsDMARDs are recommended. If active peripheral arthritis, csDMARD might be considered before b/tsDMARDs. The presence of significant structural damage, long disease duration, or HLA-B27-negative status do not contraindicate for the use of b/tsDMARDs. CONCLUSIONS: These recommendations are intended to complement guidelines by helping health professionals address and manage specific groups of patients, particular clinical scenarios, and gaps in axSpA.
dc.language.iso eng
dc.publisher SPRINGER
dc.rights Atribución-NoComercial-SinDerivadas 3.0 España
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/es/ *
dc.title Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert's Document Based on a Systematic Literature Review and Extended Delphi Process
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 37450194
dc.relation.publisherversion https://link.springer.com/10.1007/s40744-023-00575-9
dc.identifier.doi 10.1007/s40744-023-00575-9
dc.journal.title Rheumatology and Therapy
dc.identifier.essn 2198-6584


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta